AirSculpt Technologies, Inc. (AIRS) vs Immuneering Corporation (IMRX)
A side-by-side comparison of AirSculpt Technologies, Inc. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.98HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
IMRX
Immuneering Corporation
$3.95HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — AIRS vs IMRX
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)IMRX -85.1% (-31.7%/yr)IMRX compounded faster over this window
AIRS IMRX
AIRS vs IMRX: by the numbers
- •IMRX is the larger company ($143M vs $139M market cap).
- •Both run net losses; IMRX's is the smaller (0.00% vs -7.79% net margin).
Metrics side by side
Valuation
| Metric | AIRS | IMRX |
|---|---|---|
| P/S ratio | 0.92 | N/A |
| P/B ratio | 1.33 | 0.75 |
| EV / EBITDA | 449.35 | N/A |
| FCF yield | 0.55% | N/A |
Profitability
| Metric | AIRS | IMRX |
|---|---|---|
| Gross margin | 57.63% | 0.00% |
| Operating margin | -7.85% | 0.00% |
| Net margin | -7.79% | 0.00% |
| ROE | -11.20% | -30.03% |
| ROIC | -7.01% | -32.73% |
Growth (annualized)
| Metric | AIRS | IMRX |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | N/A |
| FCF CAGR (5Y) | -52.36% | N/A |
| Total return CAGR (5Y) | N/A | -32.77% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.